Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.
Andrew Sedgwick
Advertisement
Articles by Andrew Sedgwick
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2025: New approaches to managing age-related eye conditions
2
AAOpt 2025: Dry eye and its neurological implications
3
AAOpt 2025: SightGlass Vision CEO Andrew Sedgwick on what's next for DOT spectacle lenses
4
AAOpt 2025: Where low-level light therapies stand as dry eye treatments and myopia management
5
.png "Optometry Times"){kind=logo}
